• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫组织化学方法和系统共核蛋白采样研究 (S4) 的组织病理学判断。

Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4).

机构信息

Civin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, Arizona.

Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F Hoffman-La Roche, Ltd, Basel, Switzerland.

出版信息

J Neuropathol Exp Neurol. 2018 Sep 1;77(9):793-802. doi: 10.1093/jnen/nly056.

DOI:10.1093/jnen/nly056
PMID:30107604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6097838/
Abstract

Immunohistochemical (IHC) α-synuclein (Asyn) pathology in peripheral biopsies may be a biomarker of Parkinson disease (PD). The multi-center Systemic Synuclein Sampling Study (S4) is evaluating IHC Asyn pathology within skin, colon and submandibular gland biopsies from 60 PD and 20 control subjects. Asyn pathology is being evaluated by a blinded panel of specially trained neuropathologists. Preliminary work assessed 2 candidate immunoperoxidase methods using a set of PD and control autopsy-derived sections from formalin-fixed, paraffin-embedded blocks of the 3 tissues. Both methods had 100% specificity; one, utilizing the 5C12 monoclonal antibody, was more sensitive in skin (67% vs 33%), and was chosen for further use in S4. Four trainee neuropathologists were trained to perform S4 histopathology readings; in subsequent testing, their scoring was compared to that of the trainer neuropathologist on both glass slides and digital images. Specificity and sensitivity were both close to 100% with all readers in all tissue types on both glass slides and digital images except for skin, where sensitivity averaged 75% with digital images and 83.5% with glass slides. Semiquantitative (0-3) density score agreement between trainees and trainer averaged 67% for glass slides and 62% for digital images.

摘要

外周组织活检免疫组化(IHC)α-突触核蛋白(Asyn)病理学可能是帕金森病(PD)的生物标志物。多中心系统性突触核蛋白采样研究(S4)正在评估来自 60 名 PD 和 20 名对照受试者的皮肤、结肠和颌下腺活检组织中的 IHC Asyn 病理学。Asyn 病理学由一组经过专门培训的神经病理学家进行盲法评估。初步工作评估了 2 种候选免疫过氧化物酶方法,使用了来自 3 种组织福尔马林固定、石蜡包埋块的 PD 和对照尸检衍生切片集。这两种方法的特异性均为 100%;一种使用 5C12 单克隆抗体,在皮肤中更敏感(67%比 33%),因此被选择用于 S4 的进一步使用。4 名受训神经病理学家接受了 S4 组织病理学阅读培训;在随后的测试中,他们的评分与培训神经病理学家在玻璃载玻片和数字图像上的评分进行了比较。除了皮肤外,所有读者在所有组织类型的玻璃载玻片和数字图像上的特异性和敏感性均接近 100%,在皮肤中,数字图像的敏感性平均为 75%,玻璃载玻片的敏感性为 83.5%。受训者和培训师之间的半定量(0-3)密度评分平均一致性为玻璃载玻片上的 67%,数字图像上的 62%。

相似文献

1
Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4).免疫组织化学方法和系统共核蛋白采样研究 (S4) 的组织病理学判断。
J Neuropathol Exp Neurol. 2018 Sep 1;77(9):793-802. doi: 10.1093/jnen/nly056.
2
In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease.帕金森病中α-突触核蛋白在多种组织和生物液中的体内分布。
Neurology. 2020 Sep 1;95(9):e1267-e1284. doi: 10.1212/WNL.0000000000010404. Epub 2020 Aug 3.
3
Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson's Disease: The Systemic Synuclein Sampling Study (S4).多中心组织和生物液 α-突触核蛋白取样用于帕金森病的可行性和安全性:系统性突触核蛋白取样研究(S4)。
J Parkinsons Dis. 2018;8(4):517-527. doi: 10.3233/JPD-181434.
4
The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's disease.系统性α-突触核蛋白抽样研究:寻找帕金森病的生物标志物
Biomark Med. 2017 Apr;11(4):359-368. doi: 10.2217/bmm-2016-0366. Epub 2017 Mar 29.
5
α-Synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson's disease patients.帕金森病患者下颌下腺α-突触核蛋白实时液滴震动诱导转化。
Mov Disord. 2020 Feb;35(2):268-278. doi: 10.1002/mds.27907. Epub 2019 Nov 23.
6
Symmetry of synuclein density in autopsied Parkinson's disease submandibular glands.帕金森病尸检下颌下腺中突触核蛋白密度的对称性。
Neurosci Lett. 2024 Mar 10;825:137702. doi: 10.1016/j.neulet.2024.137702. Epub 2024 Feb 21.
7
The Search for a Peripheral Biopsy Indicator of α-Synuclein Pathology for Parkinson Disease.寻找帕金森病α-突触核蛋白病理学的外周活检指标
J Neuropathol Exp Neurol. 2017 Jan 1;76(1):2-15. doi: 10.1093/jnen/nlw103.
8
Cutaneous Alpha-Synuclein From Paraffin Embedded Autopsy Specimens in Parkinson's Disease.帕金森病石蜡包埋尸检标本中的皮肤α-突触核蛋白
J Parkinsons Dis. 2017;7(3):503-509. doi: 10.3233/JPD-171088.
9
Submandibular gland biopsy for the diagnosis of Parkinson disease.下颌下腺活检用于帕金森病的诊断。
J Neuropathol Exp Neurol. 2013 Feb;72(2):130-6. doi: 10.1097/NEN.0b013e3182805c72.
10
Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson's disease.从胃肠道活检组织中检测到的α-突触核蛋白构象变体作为帕金森病的潜在生物标志物。
Neuropathol Appl Neurobiol. 2018 Dec;44(7):722-736. doi: 10.1111/nan.12486. Epub 2018 May 8.

引用本文的文献

1
Skin α-synuclein assays in diagnosing Parkinson's disease: a systematic review and meta-analysis.皮肤α-突触核蛋白检测在帕金森病诊断中的应用:一项系统评价和荟萃分析
J Neurol. 2025 Apr 9;272(5):326. doi: 10.1007/s00415-025-12978-5.
2
Bibliometric Analysis of Alpha-Synuclein Determination by Biopsy in Peripheral Tissues of Patients With Parkinson's Disease.帕金森病患者外周组织活检测定α-突触核蛋白的文献计量分析
Int J Telemed Appl. 2025 Feb 14;2025:6469893. doi: 10.1155/ijta/6469893. eCollection 2025.
3
Distinct subcellular localization of tau and alpha-synuclein in lewy body disease.路易体病中tau蛋白和α-突触核蛋白不同的亚细胞定位
Acta Neuropathol Commun. 2025 Jan 21;13(1):14. doi: 10.1186/s40478-024-01913-w.
4
A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson's disease.一种用于检测帕金森病皮肤中α-突触核蛋白的新型超分辨率显微镜平台。
Front Mol Neurosci. 2024 Sep 4;17:1431549. doi: 10.3389/fnmol.2024.1431549. eCollection 2024.
5
Skin Biopsy as a Diagnostic Tool for Synucleinopathies.皮肤活检作为突触核蛋白病的诊断工具
Cureus. 2023 Oct 17;15(10):e47179. doi: 10.7759/cureus.47179. eCollection 2023 Oct.
6
Fluid and Biopsy Based Biomarkers in Parkinson's Disease.基于液体和活检的帕金森病生物标志物。
Neurotherapeutics. 2023 Jul;20(4):932-954. doi: 10.1007/s13311-023-01379-z. Epub 2023 May 3.
7
Central and peripheral α-synuclein in Parkinson disease detected by seed amplification assay.帕金森病中通过种子扩增检测到的中枢和外周 α-突触核蛋白。
Ann Clin Transl Neurol. 2023 May;10(5):696-705. doi: 10.1002/acn3.51753. Epub 2023 Mar 27.
8
Salivary ATP13A2 is a potential marker of therapy-induced motor complications and is expressed by inclusions in submandibulary glands in Parkinson ´s disease.唾液腺ATP13A2是治疗引起的运动并发症的潜在标志物,在帕金森病患者的下颌下腺包涵体中表达。
Clin Park Relat Disord. 2022 Aug 28;7:100163. doi: 10.1016/j.prdoa.2022.100163. eCollection 2022.
9
Alpha-Synuclein Autoimmune Decline in Prodromal Multiple System Atrophy and Parkinson's Disease.α-突触核蛋白自身免疫在多发性系统萎缩和帕金森病前驱期的衰退。
Int J Mol Sci. 2022 Jun 12;23(12):6554. doi: 10.3390/ijms23126554.
10
Alpha-Synuclein Aggregation Pathway in Parkinson's Disease: Current Status and Novel Therapeutic Approaches.帕金森病中α-突触核蛋白聚集途径:现状与新的治疗方法。
Cells. 2022 May 24;11(11):1732. doi: 10.3390/cells11111732.

本文引用的文献

1
Skin nerve phosphorylated α-synuclein deposits in idiopathic REM sleep behavior disorder.皮肤神经中磷酸化α-突触核蛋白沉积于特发性快速眼动睡眠行为障碍。
Neurology. 2017 May 30;88(22):2128-2131. doi: 10.1212/WNL.0000000000003989. Epub 2017 May 3.
2
The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's disease.系统性α-突触核蛋白抽样研究:寻找帕金森病的生物标志物
Biomark Med. 2017 Apr;11(4):359-368. doi: 10.2217/bmm-2016-0366. Epub 2017 Mar 29.
3
Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.皮肤磷酸化α-突触核蛋白沉积证实快速眼动睡眠行为障碍为帕金森病前驱症状。
Acta Neuropathol. 2017 Apr;133(4):535-545. doi: 10.1007/s00401-017-1684-z. Epub 2017 Feb 8.
4
The Search for a Peripheral Biopsy Indicator of α-Synuclein Pathology for Parkinson Disease.寻找帕金森病α-突触核蛋白病理学的外周活检指标
J Neuropathol Exp Neurol. 2017 Jan 1;76(1):2-15. doi: 10.1093/jnen/nlw103.
5
Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson's Disease and Control Subjects.帕金森病尸检病例和对照受试者乙状结肠病理性α-突触核蛋白免疫组化方法的多中心评估
J Parkinsons Dis. 2016 Oct 19;6(4):761-770. doi: 10.3233/JPD-160888.
6
The diagnostic discrimination of cutaneous α-synuclein deposition in Parkinson disease.帕金森病中皮肤α-突触核蛋白沉积的诊断鉴别
Neurology. 2016 Aug 2;87(5):505-12. doi: 10.1212/WNL.0000000000002919. Epub 2016 Jul 6.
7
Non-Amyloid PET Imaging Biomarkers for Neurodegeneration: Focus on Tau, Alpha-Synuclein and Neuroinflammation.用于神经退行性变的非淀粉样蛋白PET成像生物标志物:聚焦于tau蛋白、α-突触核蛋白和神经炎症
Curr Alzheimer Res. 2017;14(2):169-177. doi: 10.2174/1567205013666160620111408.
8
Post-translational modifications of α-synuclein contribute to neurodegeneration in the colon of elderly individuals.α-突触核蛋白的翻译后修饰促成老年人结肠中的神经退行性变。
Mol Med Rep. 2016 Jun;13(6):5077-83. doi: 10.3892/mmr.2016.5166. Epub 2016 Apr 22.
9
Evaluation of alpha-synuclein immunohistochemical methods for the detection of Lewy-type synucleinopathy in gastrointestinal biopsies.评估用于检测胃肠道活检中路易体型突触核蛋白病的α-突触核蛋白免疫组化方法。
Acta Neuropathol Commun. 2016 Apr 4;4:35. doi: 10.1186/s40478-016-0305-8.
10
Assessment of α-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study.特发性快速眼动睡眠行为障碍患者下颌下腺α-突触核蛋白评估:病例对照研究。
Lancet Neurol. 2016 Jun;15(7):708-718. doi: 10.1016/S1474-4422(16)00080-6. Epub 2016 Mar 30.